Five-year outcomes of halt-MS: high-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe relapsing-remitting multiple sclerosis

Nash, R; Hutton, G; Racke, M; Poppat, U; Devine, S; Georges, G; Griffith, L; Muraro, P; Openshaw, H; Sayre, P; Stuve, O; Arnold, D; McConville, K; Wundes, A; Kraft, G; Bowen, J

doi:https://www.dx.doi.org/10.1038/bmt.2016.46

File(s)

abstract_658024.pdf (123.37 KB)

Accepted version

Author(s)

Nash, R

Hutton, G

Racke, M

Poppat, U

Devine, S

more

Type

Conference Paper

Date Issued

2016-03-01

Date Acceptance

2016-03-01

Citation

Bone Marrow Transplantation, 2016, 51 (Suppl 1), pp.S61-S62

URI

http://hdl.handle.net/10044/1/32479

DOI

https://www.dx.doi.org/10.1038/bmt.2016.46

ISSN

1476-5365

Publisher

Nature Publishing Group

Start Page

S61

End Page

S62

Journal / Book Title

Bone Marrow Transplantation

Volume

51

Issue

Suppl 1

Copyright Statement

Source

42nd Annual Meeting of the European Society for Blood and Marrow Transplantation

Subjects

Science & Technology

Life Sciences & Biomedicine

Biophysics

Oncology

Hematology

Immunology

Transplantation

1103 Clinical Sciences

Publication Status

Published

Start Date

2016-04-03

Finish Date

2016-04-06

Coverage Spatial

Valencia, Spain